Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil

By Weycker Derek   Taneja Charu   Edelsberg John   Erder M. Haim   Schmitt Frederick A.   Setyawan Juliana   Oster Gerry  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1187-1197

Informa Healthcare

Access to resources Recommend Favorite

Location of white matter changes and response to donepezil in patients with Alzheimer's disease: A retrospective and observational study

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 18, Iss. 1, 2018-01 ,pp. : 123-129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response

By Riepe Matthias W.   Kohler Jürgen   Horn Rolf  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1829-1835

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy

By Sakka Paraskevi   Tsolaki Magda   Hort Jakub   Hager Klaus   Soininen Hilkka   López Pousa Secundino   Li Chunming   Schwam Elias  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3153-3165

Informa Healthcare

Access to resources Recommend Favorite

Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease

By Bullock Roger   Bergman Howard   Touchon Jacques   Gambina Giuseppe   He Yunsheng   Nagel Jennifer   Lane Roger  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 483-494

Informa Healthcare

Access to resources Recommend Favorite